Uya Chuluunbaatar, PhD, is a Partner at Avoro Ventures. Prior to joining Avoro Ventures, Uya was a Principal at Amzak Health where she led private and public biotech investments. Prior to Amzak, Uya was a biotech equity research analyst at Goldman Sachs, covering large and mid-cap companies. Uya completed her Ph.D in Microbiology at New York University School of Medicine and holds a B.S. in Biochemistry from Cornell University, United States.